Evidence·Exposure / Absorption
ReportedCmax evidence
ATLXM0054456
A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.
Stack
ATLXM0054456
A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.
ATLXM0054456
A dose-dependent increase in C max and AUC 0-INF was also observed between carfilzomib 20 mg/m 2 and 56 mg/m 2 as a 2- to 10-minute infusion in patients with relapsed or refractory multiple myeloma.
This page treats the row as evidence attached to an endpoint and assay context. The layer describes how the row can be interpreted; it is not a safety or developability score by itself.
